Scientists have made a groundbreaking discovery regarding a vulnerability in amyotrophic lateral sclerosis (ALS) — and they’ve successfully managed to reverse this issue in experimental models. Researchers associated with VIB and KU Leuven have pinpointed a crucial molecular mechanism that enables motor neurons to sustain protein production, a process that is compromised in ALS. This significant research, which has been published in the esteemed journal Nature Neuroscience, uncovers an early point of weakness in the neurodegenerative process and suggests a potential target for future therapeutic interventions.
The Importance of Protein Production
Motor neurons rely heavily on local protein synthesis within their axons, which is essential for maintaining their long-range connections to muscles. Utilizing cutting-edge spatial transcriptomics techniques, the scientists from the VIB–KU Leuven Center for Brain & Disease Research conducted an in-depth analysis of gene expression, differentiating between neuron cell bodies and axons in adult mice. Surprisingly, they discovered that axons possess unexpectedly high concentrations of the molecular components necessary for protein production.
In the ALS models featuring harmful mutations in the RNA-binding protein FUS, the local system responsible for protein production was significantly hampered. The research team traced this disruption back to Eif5a, a protein integral to the translation process. For Eif5a to function effectively, it requires a specific chemical modification known as hypusination. In neurons with mutations, the active form of Eif5a was notably absent from the axons, leading to a decline in local protein synthesis.
Exploring Potential Treatments with Spermidine
Dr. Diana Piol, the first author of the study and now affiliated with the University of Padova, explained, "Our findings indicated that local translation is dependent on the levels of Dohh, an enzyme vital for the hypusination of Eif5a. When we introduced spermidine, a naturally occurring molecule essential for this modification, into the axons, we observed a restoration of Eif5a activity. This enhancement led to improved local protein production, reinforced axonal structure, and boosted neuronal activity."
Prof. Sandrine Da Cruz, the senior author of the study, elaborated on the importance of these findings: “The defects in protein synthesis begin locally in axons, well before the actual degeneration of the neurons occurs. By rejuvenating protein synthesis within the axons, we were able to mitigate damage associated with the disease in various ALS models. This breakthrough was made possible through the innovative application of spatial transcriptomics, which allowed us to analyze gene expression on a subcellular level, underscoring the pivotal role of distal axon homeostasis as a promising avenue for therapeutic targeting.”
Interestingly, the treatment with spermidine also diminished toxicity in fruit fly models exhibiting ALS characteristics linked to both FUS and TDP-43, indicating that this pathway could be relevant across different variants of the disease.
While the current research does not translate directly into an immediate treatment option, it highlights Eif5a hypusination as a compelling target for future therapies and demonstrates how spatial analysis can uncover early, compartment-specific mechanisms involved in neurodegenerative diseases.
